Progressive Reports April 2024 Results
MAYFIELD VILLAGE, OHIO, May 15, 2024 (GLOBE NEWSWIRE) — The Progressive Corporation (NYSE:PGR) today reported the following results for the […]
Scorpius Holdings Achieves Major Milestone with cGMP Facility Validation for Microbial Manufacturing
DURHAM, N.C., May 15, 2024 (GLOBE NEWSWIRE) — Scorpius Holdings, Inc (NYSE American: SCPX), (“Scorpius” or the “Company”), an integrated contract […]
Celestica Introduces Four New Enterprise Access Networking Switches
TORONTO, May 15, 2024 (GLOBE NEWSWIRE) — Celestica Inc. (TSX: CLS) (NYSE: CLS), a leader in design, manufacturing, hardware platform […]
Axalta Hosting Strategy Day; Outlining Three-Year Plan for Accelerating Performance
PHILADELPHIA, May 15, 2024 (GLOBE NEWSWIRE) — Axalta Coating Systems (NYSE: AXTA) (“Axalta”), a leading global coatings company, today will […]
Gildan Activewear Board of Directors Issues Letter to Shareholders
– Board Urges Shareholders to Vote “FOR” ALL Gildan’s Qualified and Experienced Director Nominees and Karen Stuckey and J.P. Towner […]
Le conseil d’administration de Les Vêtements de Sport Gildan adresse une lettre aux actionnaires
Le conseil presse les actionnaires de voter « POUR » TOUS les candidats aux postes d’administrateurs compétents et expérimentés de Gildan ainsi […]
Bread Financial™ Provides Performance Update for April 2024
COLUMBUS, Ohio, May 15, 2024 (GLOBE NEWSWIRE) — Bread Financial Holdings, Inc. (NYSE: BFH), a tech-forward financial services company that provides […]
ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
LAUSANNE, Switzerland, May 15, 2024 (GLOBE NEWSWIRE) — ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive […]
BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024
GAITHERSBURG, Maryland and NESS ZIONA, Israel, May 15, 2024 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (“BiomX” or the […]
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results
Continued progress enrolling in its VMT-α-NET and VMT01 clinical trials Disclosed a new internally discovered molecule that targets fibroblast activation […]
